Home | Databases | WorldLII | Search | Feedback Edited Legal Collections Data

"Contents" [2009] ELECD 473; in Castle, David (ed), "The Role of Intellectual Property Rights in Biotechnology Innovation" (Edward Elgar Publishing, 2009)

Book Title: The Role of Intellectual Property Rights in Biotechnology Innovation

Editor(s): Castle, David

Publisher: Edward Elgar Publishing

ISBN (hard cover): 9781847209801

Section Title: Contents

Number of pages: 3

Extract:

Contents
List of figures viii
List of tables ix
List of contributors x
Acknowledgements xiv

Introduction 1
David Castle

PART I INTELLECTUAL PROPERTY RIGHTS IN
INNOVATION SYSTEMS

Introduction 19
David Castle
1 Are intellectual property rights quanta of innovation? 24
J. Adam Holbrook
2 Intellectual property rights and innovation systems: issues
for governance in a global context 37
Bjørn Asheim, Finn Valentin and Christian Zeller
3 Intellectual property rights policy for gene-related
inventions ­ toward optimum balance between public
and private ownership 73
Koichi Sumikura

PART II INTELLECTUAL PROPERTY MANAGEMENT
IN BIOTECHNOLOGY

Introduction 101
Karen L. Durell
4 Fundamentals of intellectual property management 105
Patrick H. Sullivan
5 Making a return on R&D: a business perspective 118
Sharon Oriel

v
vi Intellectual property rights in biotechnology innovation

6 Looking beyond the firm: intellectual asset management
and biotechnology 133
Karen L. Durell and E. Richard Gold

PART III INTELLECTUAL PROPERTY RIGHTS IN
RELATION TO OTHER MEASURES OF
INNOVATION

Introduction 155
L. Martin Cloutier and David Castle
7 Increasing internal value from patents: the role of
organizational arrangements 159
Marc Ingham, Cecile Ayerbe, Emmanuel Métais and
Liliana Mitkova
8 Language system (LS) 3.0: an agenda for a model of
innovation valuation 178
Clinton W. Francis
9 Measurement of innovation and intellectual property
management: challenging processes 202
L. Martin Cloutier and Susanne Sirois

PART IV BEYOND PATENT LENGTH

Introduction 219
Amy J. Glass and Fabricio X. Nunez
10 Open development: is the `open source' analogy relevant
to biotechnology? 225
...